1. Home
  2. NVAX vs CCB Comparison

NVAX vs CCB Comparison

Compare NVAX & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • CCB
  • Stock Information
  • Founded
  • NVAX 1987
  • CCB 1997
  • Country
  • NVAX United States
  • CCB United States
  • Employees
  • NVAX N/A
  • CCB N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • CCB Major Banks
  • Sector
  • NVAX Health Care
  • CCB Finance
  • Exchange
  • NVAX Nasdaq
  • CCB Nasdaq
  • Market Cap
  • NVAX 1.3B
  • CCB 1.3B
  • IPO Year
  • NVAX 1995
  • CCB 2018
  • Fundamental
  • Price
  • NVAX $6.47
  • CCB $86.04
  • Analyst Decision
  • NVAX Buy
  • CCB Strong Buy
  • Analyst Count
  • NVAX 5
  • CCB 3
  • Target Price
  • NVAX $16.60
  • CCB $103.33
  • AVG Volume (30 Days)
  • NVAX 6.2M
  • CCB 77.5K
  • Earning Date
  • NVAX 08-07-2025
  • CCB 07-28-2025
  • Dividend Yield
  • NVAX N/A
  • CCB N/A
  • EPS Growth
  • NVAX N/A
  • CCB 17.53
  • EPS
  • NVAX 2.97
  • CCB 3.36
  • Revenue
  • NVAX $1,254,962,000.00
  • CCB $322,160,000.00
  • Revenue This Year
  • NVAX $56.85
  • CCB $109.11
  • Revenue Next Year
  • NVAX N/A
  • CCB $36.30
  • P/E Ratio
  • NVAX $2.17
  • CCB $25.27
  • Revenue Growth
  • NVAX 25.92
  • CCB 25.44
  • 52 Week Low
  • NVAX $5.01
  • CCB $43.01
  • 52 Week High
  • NVAX $17.81
  • CCB $102.25
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 39.95
  • CCB 50.04
  • Support Level
  • NVAX $6.26
  • CCB $81.00
  • Resistance Level
  • NVAX $7.80
  • CCB $92.63
  • Average True Range (ATR)
  • NVAX 0.36
  • CCB 2.68
  • MACD
  • NVAX -0.13
  • CCB -0.51
  • Stochastic Oscillator
  • NVAX 1.62
  • CCB 43.35

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury & administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.

Share on Social Networks: